BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25557975)

  • 21. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma.
    Hu TH; Huang CC; Lin PR; Chang HW; Ger LP; Lin YW; Changchien CS; Lee CM; Tai MH
    Cancer; 2003 Apr; 97(8):1929-40. PubMed ID: 12673720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
    Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
    J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma.
    Liu WR; Tian MX; Yang LX; Lin YL; Jin L; Ding ZB; Shen YH; Peng YF; Gao DM; Zhou J; Qiu SJ; Dai Z; He R; Fan J; Shi YH
    Oncotarget; 2015 Jan; 6(2):846-61. PubMed ID: 25514599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stabilization of LSD1 by deubiquitinating enzyme USP7 promotes glioblastoma cell tumorigenesis and metastasis through suppression of the p53 signaling pathway.
    Yi L; Cui Y; Xu Q; Jiang Y
    Oncol Rep; 2016 Nov; 36(5):2935-2945. PubMed ID: 27632941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma.
    Zhou ZJ; Dai Z; Zhou SL; Fu XT; Zhao YM; Shi YH; Zhou J; Fan J
    Int J Cancer; 2013 Mar; 132(5):1080-9. PubMed ID: 22821376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
    World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: role of the S100A4-miR155-SOCS1-MMP9 axis.
    Yan XL; Jia YL; Chen L; Zeng Q; Zhou JN; Fu CJ; Chen HX; Yuan HF; Li ZW; Shi L; Xu YC; Wang JX; Zhang XM; He LJ; Zhai C; Yue W; Pei XT
    Hepatology; 2013 Jun; 57(6):2274-86. PubMed ID: 23316018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
    Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF
    Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [High expression of thrombin receptor PAR1 in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma in early stage].
    Zhang XF; Dong QZ; Xue YH; Zhou HJ; Ye QH; Ren N; Jia HL; Qin LX
    Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):266-70. PubMed ID: 21586224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma].
    Chen G; Luo DZ; Wang Y; Liao ZL; Zhang MY
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):113-7. PubMed ID: 17493386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knockdown of WWP1 inhibits growth and induces apoptosis in hepatoma carcinoma cells through the activation of caspase3 and p53.
    Cheng Q; Cao X; Yuan F; Li G; Tong T
    Biochem Biophys Res Commun; 2014 Jun; 448(3):248-54. PubMed ID: 24792179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts.
    Mazzocca A; Dituri F; Lupo L; Quaranta M; Antonaci S; Giannelli G
    Hepatology; 2011 Sep; 54(3):920-30. PubMed ID: 21674557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
    Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
    Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma.
    Dai B; Ruan B; Wu J; Wang J; Shang R; Sun W; Li X; Dou K; Wang D; Li Y
    Int J Clin Exp Pathol; 2014; 7(9):5645-54. PubMed ID: 25337205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myeloid differentiation factor 88 promotes growth and metastasis of human hepatocellular carcinoma.
    Liang B; Chen R; Wang T; Cao L; Liu Y; Yin F; Zhu M; Fan X; Liang Y; Zhang L; Guo Y; Zhao J
    Clin Cancer Res; 2013 Jun; 19(11):2905-16. PubMed ID: 23549880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ubiquitin-specific protease 7 is a drug-able target that promotes hepatocellular carcinoma and chemoresistance.
    Zhang W; Zhang J; Xu C; Zhang S; Bian S; Jiang F; Ni W; Qu L; Lu C; Ni R; Fan Y; Xiao M; Liu J
    Cancer Cell Int; 2020; 20():28. PubMed ID: 32002017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of the Polycomb protein RING1B ubiquitination by USP7.
    de Bie P; Zaaroor-Regev D; Ciechanover A
    Biochem Biophys Res Commun; 2010 Sep; 400(3):389-95. PubMed ID: 20800574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
    Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
    J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of WAVE3 promotes tumor invasiveness and confers an unfavorable prognosis in human hepatocellular carcinoma.
    Ji Y; Li B; Zhu Z; Guo X; He W; Fan Z; Zhang W
    Biomed Pharmacother; 2015 Feb; 69():409-15. PubMed ID: 25661390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.